Work

EE232 Impact of Updated Mortality Estimates on the Cost-Effectiveness of Rifaximin for the Treatment of Patients with Overt Hepatic Encephalopathy

Year: 2023

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2023.03.533

Authors: S. Bhattacharyya, D. John, A. Thomas, P. Soni, A.B. Jesudian, A.A. Dashputre, G. Joseph

Institutions: ITC (India), City College, Kolkata, Weill Cornell Medicine, Bausch Health (United States)

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4380149923

Cites:

Cited by:

Related to: 10